justicedao/ipfs_state_laws huggingface dataset:
410-122-0600 Toilet Supplies (1) The Division may consider coverage for commodes when: (a) The client is physically incapable of utilizing regular toilet facilities. This would occur when the client is confined to: (A) A single room; or (B) One level of the home environment and there is no toilet on that level; or (C) The home and there are no toilet facilities in the home. (b) Extra-wide/heavy-duty commodes may be covered when a client weighs 300 pounds or more and meets the conditions of coverage for commodes; (c) Only bariatric commodes coded as E1399 (durable medical equipment, miscellaneous) may be covered for a client residing in a nursing facility, subject to service limitations of Division rules, when all of the following requirements are met: (A) The client meets the conditions of coverage as specified in this rule; and (B) The bariatric commode has been assigned code E1399 by the Medicare Pricing, Data Analysis and Coding (PDAC) contractor. (d) A commode with detachable arms (E0165) may be covered if the detachable arms feature is necessary to facilitate transferring the client or if the client has a body configuration that requires extra width. (e) A commode with integrated seat lift mechanism (E0170, E0171) is covered if it is medically appropriate and client meets criteria for a seat lift mechanism. A commode with seat lift mechanism is intended to allow the client to walk after standing.(f) Toilet seat lift mechanisms (E0172) and footrests (E0175) are not primarily medical in nature. (2) Documentation requirements: (a) Documentation must include the practitioner’s order, the client’s height and weight and information supporting the medical appropriateness for the commode dispensed; (b) For codes requiring prior authorization (PA), submit documentation which supports conditions of coverage are met as specified in this rule. (3) Procedure Codes: Table 122-0600 Toilet Supplies. [ED. NOTE: Tables referenced are available from the agency.] [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 23-2024, minor correction filed 01/04/2024, effective 01/04/2024 DMAP 101-2023, amend filed 12/29/2023, effective 01/01/2024 DMAP 15-2009, f. 6-12-09, cert. ef. 7-1-09 DMAP 12-2007, f. 6-29-07, cert. ef. 7-1-07 OMAP 47-2006, f. 12-15-06, cert. ef. 1-1-07 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 21-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 47-2002, f. & cert. ef. 10-1-02 OMAP 8-2002, f. & cert. ef. 4-1-02 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 4-2001, f. 3-30-01, cert. ef. 4-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00 OMAP 13-1999, f. & cert. ef. 4-1-99 HR 17-1996, f. & cert. ef. 8-1-96 HR 26-1994, f. & cert. ef. 7-1-94 HR 10-1994, f. & cert. ef. 2-15-94 HR 9-1993, f. & cert. ef. 4-1-93 HR 32-1992, f. & cert. ef. 10-1-92 HR 13-1991, f. & cert. ef. 3-1-91
410-122-0620 Miscellaneous Supplies Procedure Codes — Table 122-0620. [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 87-2025, amend filed 12/09/2025, effective 12/09/2025 DMAP 15-2009, f. 6-12-09, cert. ef. 7-1-09 DMAP 12-2007, f. 6-29-07, cert. ef. 7-1-07 OMAP 47-2006, f. 12-15-06, cert. ef. 1-1-07 OMAP 35-2006, f. 9-15-06, cert. ef. 10-1-06 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 25-2004, f. & cert. ef. 4-1-04 OMAP 21-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 47-2002, f. & cert. ef. 10-1-02 OMAP 8-2002, f. & cert. ef. 4-1-02 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00 OMAP 32-1999, f. & cert. ef. 10-1-99 OMAP 13-1999, f. & cert. ef. 4-1-99 OMAP 11-1998, f. & cert. ef. 4-1-98 HR 7-1997, f. 2-28-97, cert. ef. 3-1-97 HR 17-1996, f. & cert. ef. 8-1-96 HR 41-1994, f. 12-30-94, cert. ef. 1-1-95 HR 10-1994, f. & cert. ef. 2-15-94 HR 9-1993, f. & cert. ef. 4-1-93 HR 10-1992, f. & cert. ef. 4-1-92 HR 13-1991, f. & cert. ef. 3-1-91
410-122-0625 Surgical Dressing Procedure Codes: Table 122-0625 Surgical Dressing. [ED. NOTE: Tables referenced are available from the agency.] [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 13-2010, f. 6-10-10, cert. ef. 7-1-10 DMAP 12-2007, f. 6-29-07, cert. ef. 7-1-07 OMAP 35-2006, f. 9-15-06, cert. ef. 10-1-06 OMAP 11-2005, f. 3-9-05, cert. ef. 4-1-05 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 25-2004, f. & cert. ef. 4-1-04 OMAP 21-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 8-2002, f. & cert. ef. 4-1-02 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 4-2001, f. 3-30-01, cert. ef. 4-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00
410-122-0640 Eye Prostheses (1) Indications and coverage: (a) An eye prosthesis is indicated for a client (adult or child) with absence or shrinkage of an eye due to birth defect, trauma, or surgical removal; (b) For clients under age 21, the prescribing practitioner shall determine and document medical appropriateness of the eye prosthesis and related services; (c) For clients age 21 and older, coverage is limited as follows: (A) Polishing and resurfacing will be allowed on a twice per year basis; (B) Replacement is covered every five years if documentation supports medical appropriateness. An exception to this limitation is allowed when clinical documentation supports medical appropriateness for more frequent replacement; (C) One enlargement (V2625) or reduction (V2626) of the prosthesis is covered. Additional enlargements or reductions are rarely medically indicated and are therefore covered only when clinical documentation supports medical appropriateness. (2) Documentation requirements: (a) An order for each item shall be signed and dated by the treating physician, kept on file by the supplier, and made available upon request; (b) Documentation of medical appropriateness that has been reviewed and signed by the prescribing practitioner shall be kept on file by the supplier and made available upon request; (c) When billing for an item or service at a greater frequency than allowed, there shall be documentation in the patient’s medical records that corroborates the order and supports the medical appropriateness of the items. This documentation shall be kept on file by the supplier and available upon request. (3) Procedure Codes – Table 122-0640. [ED. NOTE: Tables referenced are available from the agency.] [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 25-2024, minor correction filed 01/04/2024, effective 01/04/2024 DMAP 101-2023, amend filed 12/29/2023, effective 01/01/2024 DMAP 11-2016, f. 2-24-16, cert. ef. 3-1-16 DMAP 60-2014, f. 10-3-14, cert. ef. 10-7-14 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00 HR 17-1996, f. & cert. ef. 8-1-96 HR 10-1994, f. & cert. ef. 2-15-94 HR 9-1993, f. & cert. ef. 4-1-93 HR 13-1991, f. & cert. ef. 3-1-91
410-122-0655 External Breast Prostheses (1) Indications and Limitations of Coverage and Medical Appropriateness: (a) The Division may cover an external breast prosthesis for a client who has had a mastectomy; (b) An external breast prosthesis garment, with mastectomy form (L8015) may be covered for use in the postoperative period prior to a permanent breast prosthesis or as an alternative to a mastectomy bra and breast prosthesis; (c) An external breast prosthesis of a different type may be covered if there is a change in the client’s medical condition necessitating a different type of item; (d) The Division will pay for only one breast prosthesis per side for the useful lifetime of the prosthesis; (e) The Division will pay for a breast prosthesis for a client residing in a nursing facility; (f) Two prostheses, one per side, are allowed for a client who has had bilateral mastectomies; (g) More than one external breast prosthesis per side is not covered; (h) An external breast prosthesis of the same type may be replaced if it is lost or is irreparably damaged (this does not include ordinary wear and tear); (i) Replacement sooner than the useful lifetime because of ordinary wear and tear is not covered. (2) Guidelines: (a) Use code A4280 when billing for an adhesive skin support that attaches an external breast prosthesis directly to the chest wall; (b) L8000 is limited to a maximum of four units every 12 months; (c) Code L8015 describes a camisole type undergarment with polyester fill used post mastectomy; (d) The right (RT) and left (LT) modifiers must be used with these codes. When the same code for two breast prostheses are billed for both breasts on the same date, the items (RT and LT) must be entered on the same line of the claim form using the RTLT modifier and two units of service; (e) The useful lifetime expectancy for silicone breast prostheses is two years; (f) For fabric, foam, or fiber filled breast prostheses, the useful lifetime expectancy is six months. (3) Requirements: (a) For services that do not require prior authorization (PA), the durable medical equipment, prosthetic, orthotic and supplies (DMEPOS) provider must have documentation on file which supports conditions of coverage as specified in this rule are met; (b) For services that require PA, the DMEPOS provider must submit documentation for review which supports conditions of coverage as specified in this rule are met; (c) Medical records must be made available to the Division on request. (4) Table 122-0655 (Procedure Codes): The procedure codes in this table may be covered for purchase. [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 13-2010, f. 6-10-10, cert. ef. 7-1-10 DMAP 37-2008, f. 12-11-08, cert. ef. 1-1-09 Renumbered from 410-122-0255, DMAP 12-2007, f. 6-29-07, cert. ef. 7-1-07 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 47-2002, f. & cert. ef. 10-1-02 OMAP 8-2002, f. & cert. ef. 4-1-02 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00
410-122-0660 Orthotics and Prosthetics (1) Indications and limitations of coverage and medical appropriateness: (a) The Division may cover some orthotics and prosthetics for covered conditions; (b) Use the current Healthcare Common Procedure Coding System (HCPCS) Level II Guide for current codes and descriptions; (c) For adults, follow Medicare current guidelines for determining coverage; (d) For clients under age 21, the prescribing practitioner shall determine and document medical appropriateness; (e) The hospital is responsible for reimbursing the provider for orthotics and prosthetics provided on an inpatient basis; (f) Evaluations, office visits, fittings, and materials are included in the service provided; (g) Evaluations will only be reimbursed as a separate service when the provider travels to a client’s residence to evaluate the client’s need; (h) See Division 129, Speech-Language Pathology, Audiology and Hearing Aid Services for coverage criteria for speech and audiology prosthetic devices and accessories. (i) See OAR 410-122-0658 for coverage criteria for mastectomy sleeves (L8010). (2) Documentation requirements: (a) For services that require prior authorization (PA): Submit documentation for review that supports conditions of coverage as specified in this rule are met; (b) For services that do not require PA: Medical records that support conditions of coverage as specified in this rule are met shall be on file with the durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) provider and made available to the Division on request. (3) Table 122-0660-1: Codes requiring PA. [ED. NOTE: Tables referenced are available from the agency.] [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 27-2024, minor correction filed 01/04/2024, effective 01/04/2024 DMAP 101-2023, amend filed 12/29/2023, effective 01/01/2024 DMAP 60-2015, f. 10-29-15, cert. ef. 11-1-15 DMAP 17-2012, f. 3-30-12, cert. ef. 4-1-12 DMAP 40-2009, f. 12-15-09, cert. ef. 1-1-10 DMAP 17-2008, f. 6-13-08, cert. ef. 7-1-08 OMAP 47-2006, f. 12-15-06, cert. ef. 1-1-07 OMAP 35-2006, f. 9-15-06, cert. ef. 10-1-06 OMAP 11-2005, f. 3-9-05, cert. ef. 4-1-05 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 25-2004, f. & cert. ef. 4-1-04 OMAP 21-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 47-2002, f. & cert. ef. 10-1-02 OMAP 8-2002, f. & cert. ef. 4-1-02 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 4-2001, f. 3-30-01, cert. ef. 4-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00 OMAP 1-2000, f. 3-31-00, cert. ef. 4-1-00 OMAP 13-1999, f. & cert. ef. 4-1-99 OMAP 11-1998, f. & cert. ef. 4-1-98 HR 7-1997, f. 2-28-97, cert. ef. 3-1-97 HR 17-1996, f. & cert. ef. 8-1-96 HR 41-1994, f. 12-30-94, cert. ef. 1-1-95 HR 26-1994, f. & cert. ef. 7-1-94 HR 10-1994, f. & cert. ef. 2-15-94 HR 9-1993, f. & cert. ef. 4-1-93 HR 10-1992, f. & cert. ef. 4-1-92 HR 13-1991, f. & cert. ef. 3-1-91
410-122-0678 Dynamic Adjustable Extension/Flexion Device (1) Indications and limitations of coverage and medical appropriateness: The Division may cover some dynamic adjustable extension/flexion devices for a covered condition when all of the following conditions are met: (a) As an adjunct to physical therapy for clients with signs and symptoms of persistent joint stiffness in the sub-acute injury or post-operative period (> 3 weeks but < 4 months after injury or surgical procedure) when the device is applied and managed under the direct supervision of a physical therapist; (b) As an adjunct to physical therapy in the acute post-operative period for clients who are undergoing additional surgery to improve the range of motion of a previously affected joint when the device is managed under the direct supervision of a physical therapist; (c) For this episode, the device has not been billed to the Division with a current procedure terminology (CPT) code, healthcare common procedure coding system (HCPCS) code, or diagnosis code by any other healthcare provider; (d) Reimbursement is limited to a maximum of four (4) months per episode; (e) Reimbursement is on a month-to-month rental basis only. (2) Documentation requirements: (a) Submit medical records that support the conditions of coverage, as specified in this rule, have been met, including the treatment plan from the physical therapist; (b) The treatment plan shall include: (A) Baseline measurements (pre-intervention measurements) of range of motion (ROM) limitations; (B) Weekly ROM measurements with documented 10 degree improvement. (3) Refer to Table 122-0678 — Dynamic Adjustable Extension/Flexion Devices for HCPCS codes. [ED. NOTE: To view attachments referenced in rule text, click here to view rule.] Statutory/Other Authority: ORS 413.042 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 87-2025, amend filed 12/09/2025, effective 12/09/2025 DMAP 11-2016, f. 2-24-16, cert. ef. 3-1-16 DMAP 15-2007, f. 12-5-07, cert. ef. 1-1-08 OMAP 47-2006, f. 12-15-06, cert. ef. 1-1-07 OMAP 44-2004, f. & cert. ef. 7-1-04 OMAP 21-2003, f. 3-26-03, cert. ef. 4-1-03 OMAP 8-2002, f. & cert. ef. 4-1-02 OMAP 32-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 4-2001, f. 3-30-01, cert. ef. 4-1-01 OMAP 37-2000, f. 9-29-00, cert. ef. 10-1-00
410-123-1250 HbA1c Testing (1) The Authority covers Hemoglobin A1c (HbA1c) testing for at risk members per scope of practice for Oregon licensed oral health providers. (2) Although not presumed to be a standard of care, testing serves as a resource for licensed oral health providers which supports identification of those members with HbA1c levels that are above the “normal range", and that can affect periodontal status, wound healing, infection control and other conditions of the oral environment. (3) Licensed oral health providers must share the HbA1c test results with the member’s primary care provider (PCP) to promote care collaboration and avoid duplication, and: (a) Establish bi-directional communication with the member’s PCP to communicate test results and initiate a referral for evaluation, diagnosis, treatment, and collaboration of care; and (b) Communicate progress of treatment and oral health status. (4) Licensed oral health providers must comply with OAR 410-130-0680, as it pertains to blood testing, and 42 CFR §493 and OAR 333-024-0005 through 333-024-0055, as it pertains to Clinical Laboratory Improvement Amendments (CLIA): (a) Information about CLIA in Oregon including enrollment requirements and processes is located on the Authority’s Clinical Laboratory Regulation webpage https://www.oregon.gov/oha/PH/LaboratoryServices/ClinicalLaboratoryRegulation/Pages/index.aspx; (b) In order to perform HbA1c testing, Oregon licensed oral health providers and facilities must apply for a Certificate of Waiver (CMS-116 application form), available on the CLIA webpage; and (c) Waived tests are not exempt from CLIA certification. For more information, refer to https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments. (5) In determining the need for HbA1c testing, licensed oral health providers must use best clinical judgement when considering member risk factors based on appropriate, consensus-based guidelines. (6) Release of Information (ROI): (a) Licensed oral health providers must ensure a member’s ROI is on file in the member’s record; (b) If the member does not have a PCP, licensed oral health providers must: (A) Inform the member of the test findings and direct them toward resources containing more information and encourage the member to become a patient of record with a PCP for their other health needs; and (B) Document actions in the member’s record, with follow-up at the next visit. (c) Referrals must be tracked and documented in the member’s record; (d) Licensed oral health providers must provide sufficient information regarding the purpose of the test and the procedure, including their relevance to both oral and general health, so that a member can make an informed decision; and (e) Members may decline testing. Statutory/Other Authority: ORS 679.543 & 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 93-2025, amend filed 12/22/2025, effective 01/01/2026 DMAP 139-2024, amend filed 12/06/2024, effective 01/01/2025 DMAP 63-2024, minor correction filed 02/21/2024, effective 02/21/2024 DMAP 50-2021, amend filed 12/24/2021, effective 01/01/2022 DMAP 65-2019, adopt filed 12/26/2019, effective 01/01/2020
410-123-1510 Additional Dental Benefits for Pregnant and Postpartum Members (1) This rule sets forth the access standards for dental care for members who are pregnant or 12 months postpartum. (2) Pregnant members must be seen, treated in person or via teledentistry for the following OHP-covered service and within the following time frames: (a) Emergency dental care: within 24 hours; (b) Urgent dental care: within one (1) week. (c) Routine dental care: within four (4) weeks, unless there is a documented special clinical reason that may make it appropriate to be seen or treated beyond this time frame; (d) Initial dental screening or examination: within four (4) weeks. (3) The following additional dental services are available to pregnant members if authorized as medically or dentally necessary due to the pregnancy: (a) Prophylaxis, fluoride, and periodontal services; (b) Permanent crowns and resin-based composite crowns for anterior teeth; (c) Prefabricated post and core; (d) Root canals on first molars; (e) Apexification/recalcification, pulpal regeneration; and (f) Alveoloplasty not in conjunction with extractions. (4) Nothing in this rule obligates a pregnant member to accept an offered service. Statutory/Other Authority: ORS 413.042 & ORS 414.065 Statutes/Other Implemented: ORS 414.065 History: DMAP 93-2025, amend filed 12/22/2025, effective 01/01/2026 DMAP 141-2024, temporary suspend filed 12/10/2024, effective 01/01/2025 through 06/29/2025 DMAP 68-2024, minor correction filed 02/22/2024, effective 02/22/2024 DMAP 74-2022, amend filed 09/23/2022, effective 09/25/2022 DMAP 44-2022, temporary amend filed 03/29/2022, effective 04/01/2022 through 09/27/2022 DMAP 13-2022, amend filed 02/09/2022, effective 02/09/2022 DMAP 50-2021, amend filed 12/24/2021, effective 01/01/2022 DMAP 28-2016, f. & cert. ef. 6-28-16 DMAP 82-2015(Temp), f. 12-23-15, cert. ef. 1-1-16 thru 6-28-16
410-124-0000 Transplant Services (1) The Health Systems Division (Division) shall make payment for transplant services identified in these rules as covered for eligible Medicaid clients defined in OAR 410-124-0010 that meet the transplant criteria outlined in OAR 410-124-0000 through 410-124-0040 and the Prioritized List of Health Services guideline notes. (2) The Division shall reimburse for transplants if: (a) All Division criteria are met; and (b) T ransplants are medically necessary and meet the requirements for physician and hospital services ; and (c) The ICD-10-CM diagnosis code(s) and CPT transplant procedure code(s) are paired on the same currently funded line on the Prioritized List of Health Services adopted under OAR 410-141-3830. (3) The following transplants are covered by the Division if the criteria in (2) above is met: (a) Solid organ, heart, kidney, liver, lung, heart-lung, pancreas, kidney-pancreas, and small bowel; (b) Bone marrow and peripheral stem cell; (c) Corneal transplants; (d) Simultaneous multiple organ transplants are covered only if specifically identified as paired on the same currently funded line on the Oregon Health Plan (OHP) Prioritized List of Health Services whether the transplants are for the same underlying disease or for unrelated, but concomitant, underlying diseases. (4) Not Covered Transplant Services: The following types of transplants are not covered by the Division: (a) Transplants which are considered experimental or investigational or which are performed on an experimental or investigational basis, as determined by the Division; (b) Second bone marrow transplants are not covered except for tandem autologous transplants for multiple myeloma. (c) Transplants which are not described as covered in OAR 410-141-3830. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.065 History: DMAP 49-2023, amend filed 06/30/2023, effective 07/01/2023 DMAP 2-2023, temporary amend filed 01/31/2023, effective 02/01/2023 through 07/30/2023 DMAP 51-2015, f. 9-22-15, cert. ef. 10-1-15 OMAP 95-2004(Temp), f. & cert. ef, 12-30-04 thru 3-15-05 OMAP 92-2004(Temp), f.& cert. ef. 12-10-04 thru 3-15-05 OMAP 68-2004(Temp), f. 9-14-04, cert. ef. 10-1-04 thru 3-15-05 OMAP 1-2003, f. 1-31-03, cert. ef. 2-1-03 OMAP 34-2001, f. 9-24-01, cert. ef. 10-1-01 OMAP 21-2001, f. 3-30-01, cert. ef. 4-1-01 OMAP 18-2000, f. 9-28-00, cert. ef. 10-1-00 HR 17-1997, f. & cert. ef. 7-11-97 HR 19-1995, f. 9-28-95, cert. ef. 10-1-95 HR 4-1994, f. & cert. ef. 2-1-94 HR 17-1992, f. & cert. ef. 7-1-92 HR 37-1990, f. 11-6-90, cert. ef. 11-9-90 HR 22-1990, f. & cert. ef. 7-17-90 HR 8-1990(Temp), f. 3-30-90, cert. ef. 4-1-90
410-124-0005 Donor Services (1) Living and cadaver donor search and procurement services are covered for medically necessary transplants. (2) All living or cadaver donor services are payable under the recipient’s Medicaid identification number and not under the donor. (3) For Managed Care Entity(MCE) clients, contact the client’s MCE for authorization requirements. Statutory/Other Authority: ORS 413.042 Statutes/Other Implemented: ORS 414.065 History: DMAP 49-2023, amend filed 06/30/2023, effective 07/01/2023 DMAP 2-2023, temporary amend filed 01/31/2023, effective 02/01/2023 through 07/30/2023 OMAP 18-2000, f. 9-28-00, cert. ef. 10-1-00